231 related articles for article (PubMed ID: 6286101)
1. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.
Olsson IL; Breitman TR; Gallo RC
Cancer Res; 1982 Oct; 42(10):3928-33. PubMed ID: 6286101
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents.
Olsson IL; Breitman TR
Cancer Res; 1982 Oct; 42(10):3924-7. PubMed ID: 6286100
[TBL] [Abstract][Full Text] [Related]
3. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
Hemmi H; Breitman TR
Jpn J Cancer Res; 1985 May; 76(5):345-51. PubMed ID: 2989063
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.
Olsson I; Gullberg U; Ivhed I; Nilsson K
Cancer Res; 1983 Dec; 43(12 Pt 1):5862-7. PubMed ID: 6315218
[TBL] [Abstract][Full Text] [Related]
5. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.
Gullberg U; Nilsson E; Einhorn S; Olsson I
Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582
[TBL] [Abstract][Full Text] [Related]
6. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-mediated decrease of G (alpha S) protein expression: involvement of G (alpha S) in the differentiation of HL-60 myeloid cells.
Meissner JD; Brown GA; Mueller WH; Scheibe RJ
Exp Cell Res; 1996 May; 225(1):112-21. PubMed ID: 8635503
[TBL] [Abstract][Full Text] [Related]
8. Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells.
Lando M; Abemayor E; Verity MA; Sidell N
Cancer Res; 1990 Feb; 50(3):722-7. PubMed ID: 2153444
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
Mira-y-Lopez R
J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
[TBL] [Abstract][Full Text] [Related]
10. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL60) cells induced to differentiate by retinoic acid.
Fontana JA; Emler C; Ku K; McClung JK; Butcher FR; Durham JP
J Cell Physiol; 1984 Jul; 120(1):49-60. PubMed ID: 6588051
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Chapekar MS; Hartman KD; Knode MC; Glazer RI
Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
[TBL] [Abstract][Full Text] [Related]
13. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells.
Jun CD; Pae HO; Yoo JC; Kwak HJ; Park RK; Chung HT
Cell Immunol; 1998 Jan; 183(1):13-21. PubMed ID: 9578715
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
15. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells.
Chaplinski TJ; Bennett TE; Caro JF
Cancer Res; 1986 Mar; 46(3):1203-7. PubMed ID: 3002611
[TBL] [Abstract][Full Text] [Related]
16. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
17. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
18. Maturation of human promyelocytic leukemia cells induced by nicotinamide: evidence of a regulatory role for ADP-ribosylation of chromosomal proteins.
Lucas DL; Tanuma S; Davies PJ; Wright DG; Johnson GS
J Cell Physiol; 1984 Nov; 121(2):334-40. PubMed ID: 6149227
[TBL] [Abstract][Full Text] [Related]
19. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
20. Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype.
Masciulli R; Testa U; Barberi T; Samoggia P; Tritarelli E; Pustorino R; Mastroberardino G; Camagna A; Peschle C
Cell Growth Differ; 1995 May; 6(5):493-503. PubMed ID: 7647032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
